IP Library Granted Patent US 6,896,891
Granted Patent B2
US 6,896,891 · App. 09/780,646 · Granted May 24, 2005

Non-systemic control of parasites

Assignee: Bayer Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,896,891
App. No.
09/780,646
Granted
May 24, 2005
Kind
B2
Abstract

Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

Claims (38)

1. A method for controlling a parasitic insect selected from fleas and lice on a human or animal, said method comprising contacting said parasitic insect with an effective amount therefor of a compound of the formula:

wherein

n represents 1 or 2;

Subat. represents halogen;

A and Z together with the nitrogen and carbon atom to which they are bonded form a saturated heterocyclic ring having 6 ring members, said hterocyclic ring containing in addition to the nitrogen atom to which A is bonded a further hetero group, said hetero group being selected from N—H and N-alkyl, wherein the alkyl of said N-alkyl has 1 to 4 carbon atoms;

E represents NO 2 or CN; and

X represents —CH═ or —N═;

wherein said contacting of said parasitic insect with said compound is effected by:

a) topically applying said compound to the dermis of said human or animal; or

b) contacting the dermis of said human or animal with an article containing said compound,

and wherein said contacting of said parasitic insect with said compound does not result in said compound being systemically distributed within said human or animal.

2. The method according to claim 1 , which comprises contacting said parasitic insect with the compound:

3. The method according to claim 1 , wherein the animal is a dog or cat infested with fleas.

4. The method according to claim 3 , wherein said contacting is effected by applying said compound topically to the dermis of said dog or cat by a pour-on or spot-on method.

5. The method according to claim 3 , wherein said contacting is effected by contacting the dermis of said dog or cat with an article containing said compound.

6. The method according to claim 1 , which is carried out on a human, and the human is infected with lice.

7. A method far controlling fleas on a dog or a cat, said method comprising contacting said fleas with an effective amount therefor of a compound of the formula:

wherein

a represents 1 or 2;

Subst. represents halogen;

A and Z together with the nitrogen and carbon atom to which they are bonded form a saturated heterocyclic ring having 6 ring members, said heterocyclic ring containing in addition to the nitrogen atom to which A is bonded a further hetero group, said hetero group being selected from N—H and N-alkyl, wherein the alkyl of said N-alkyl has 1 to 4 carbon atoms;

E represents NO 2 or CN; and

X represents —CH═ or —N═;

wherein said contacting of said fleas with said compound is effected by:

a) topically applying said compound to the dermis of said dog or cat; or

b) contacting the dermis of said dog or cat with an article containing said compound,

and wherein said contacting of said fleas with said compound does not result in said compound being systemically distributed within said dog or cat.

8. A method for controlling lice on a human, said method comprising contacting said lice with an effective amount therefor of a compound of the formula:

wherein

n represents 1 or 2;

Subst. represents halogen;

A and Z together with the nitrogen and carbon atom to which they are bonded form a saturated heterocyclic ring having 6 ring members, said heteroyclic ring containing in addition to the nitrogen atom to which A is bonded a further hetero group, said hetero group being selected from N—H and N-alkyl, wherein the alkyl of said N-alkyl has 1 to 4 carbon atoms;

E represents NO 2 or CN; and

X represents —CH═ or —N═;

wherein said contacting of said lice with said compound is effected by:

a) topically applying said compound to the dermis of said human; or

b) contacting the dermis of said human with an article containing said compound,

and wherein said contacting of said lice with said compound does not result in said compound being systemically distributed within said human.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2012
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029199/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2009
From: BAYER HEALTHCARE AG
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 022191/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2005
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 016182/0194 →
Priority Claims (1)
DE P 4417742 · May 20, 1994 · national
Continuity (3)
Division 0892537200 · Sep 8, 1997
Continuation 0844042800 · May 12, 1995
Related Publication 20010027201A1 · Oct 4, 2001